JUL 18, 2017 05:44 AM PDT

Old Antibiotic as a New Antidepressant?

WRITTEN BY: Xuan Pham

An old antibiotic that’s been around since the 1970s could be repurposed to be a new antidepressant. So far, researchers from the Deakin University have gathered data from the first clinical trial showing that minocycline can improve outcome for people with major depression.

Image credit: Pixabay.com

The researchers began their investigation with the observation that depression can be accompanied by cellular inflammation. "There is evidence to suggest that people with major depressive disorder have increased levels of inflammation in their body," said Dr. Olivia Dean, the study’s lead author.

Based on this observation, the team set out to investigate whether treating the inflammation with antibiotics could alleviate symptoms of depression. They chose minocycline because this drug has been shown to “reduce oxidative stress and promote neuronal growth.”

"Specifically, minocycline reduces brain inflammation in cell models, and thus we wanted to see if it was useful for people,” said Dr. Dean.

Of note, minocycline is a broad-spectrum antibiotic that is often used to treat acne vulgaris. Other infections for which minocycline is prescribed include urinary tract infections, respiratory infections, gonorrhea, tick fever, and chlamydia.

The current clinical trial involved 71 people diagnosed with major depression. Patients were randomized to a 12-week trial in which they either received minocycline or placebo in addition to usual treatment for major depressive disorder.

"We found that those on minocycline reported significant improvements in functioning, quality of life, global impression of their illness, and there was also a trend towards improvements in anxiety symptoms,” said Dr. Dean.

It's exciting when a pre-existing drug shows promise for a new disease because things tend to move much faster when this happens. "Existing medications have known safety profiles and are readily accessible," explained Dr. Dean. With the toxicity and pharmacokinetics of a drug already known, makers can shave off as much as 15 years off the pipeline to get the drug to patients' hands. But given the small size of the trial, the team is cautiously optimistic about the antibiotic’s function as a new antidepressant. However, the results suggest a broader implication, that there are great but untapped potential for old drugs. "We've found that using old medications for new purposes is very useful," she said.

"Current antidepressants are useful, but many people find a gap between their experience before becoming unwell and their recovery following treatment," Dr. Dean said. "We aim to fill this gap by providing new, biologically-based, treatments for depression. We're also considering a study of minocycline for people with anxiety disorders, given what we have found in this study.”

Minocycline is not without side effects. Most notably, the drug can cause harm to the unborn fetus or newborn babies who take breastmilk. Other common side effects include dizziness, headache, vomiting, and increased sensitivity to sunlight.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Cancer
APR 24, 2018
Synthetic Retinoid Shows Promise for Inhibition of Cancer Cells
Researchers studied the potential use of a synthetic retinoid, WYC-209, as an inhibitor of cancer cell growth and metastasis via the retinoic acid receptor pathway....
APR 25, 2018
Clinical & Molecular DX
APR 25, 2018
Why is dementia going unnoticed in hospitals?
A study in the UK showed that while the rate of diagnosis for dementia is improving, more than a third of all dementia patients still go undiagnosed. The n...
MAY 20, 2018
Clinical & Molecular DX
MAY 20, 2018
EEG Helps Determine the Right Depression Treatment
Scientists want to find effective treatments for mental health disorders, by looking to physiological markers of health and disease....
MAY 21, 2018
Genetics & Genomics
MAY 21, 2018
Using CRISPR for High-throughout Genetic Assessment
Researchers can now move beyond the painstaking manipulation of individual genes....
JUN 30, 2018
Immunology
JUN 30, 2018
CD4 T Cells Responsible for Inflammatory Bowel Disease
A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study point...
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Bubbles and a blood test could detect brain tumors
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple blood test, rather than a complicat...
Loading Comments...